Literature DB >> 31378906

Regulatory mechanism of mesalazine on TLR4/MyD88-dependent pathway in mouse ulcerative colitis model.

Y Li1, Q Liu, J-H Tang, J-J Wen, J-Q Zhu.   

Abstract

OBJECTIVE: The aim of this study was to investigate the regulatory mechanism of mesalazine (MSLZ) on microRNA-21, microRNA-31 and Toll-like receptor 4/myeloid differentiation primary response 88 (TLR4/MyD88)-dependent pathway in 2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol-induced ulcerative colitis (UC) model in mice.
MATERIALS AND METHODS: The UC model was constructed by coloclysis of TNBS/ethanol in mice. 60 male mice were randomly assigned into control group, model group, MSLZ group and Azathioprine (AZA) group, with 15 mice in each. Corresponding drug or saline was i.g. injected in mice for consecutive 14 days. Pathological lesions in colon tissues were observed by hematoxylin and eosin (HE) staining under the microscope. The expression levels of microRNA-21 and microRNA-31 in mouse colon tissues were determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The mRNA and protein levels of relative genes in TLR4/MyD88-dependent pathway in mouse colon tissues were detected by qRT-PCR and Western blot, respectively.
RESULTS: A mouse UC model was successfully constructed based on scores of DAI, colonic damage and pathological lesions under the microscope. MSLZ markedly improved clinical symptoms and mucosal healing. Meanwhile, the protective effect of MSLZ was similar or even stronger than that of AZA. The expression levels of microRNA-21 and microRNA-31 in mouse colon tissues in the model group were significantly higher than those of the control group (p<0.01). Compared with the model group, both MSLZ and AZA treatment could remarkably inhibit the expressions of microRNA-21 and microRNA-31 (p<0.01). The mRNA and protein levels of relative genes in TLR4/MyD88-dependent pathway in mouse colon tissues were markedly upregulated in the model group when compared with those of the control group. The inhibitory effect of MSLZ on the expressions of upstream factors in TLR4/MyD88-dependent pathway (including TLR4, MyD88, TRAF-6 and NF-κB) was slightly stronger than AZA, which was weaker in inhibiting downstream factors (including TNF-α and IL-1β). However, no significant difference in the inhibition of TLR4/MyD88-dependent pathway was found between MSLZ and AZA (p>0.05).
CONCLUSIONS: In the TNBS/ethanol-induced UC mouse model, MSLZ could inhibit the expressions of microRNA-21 and microRNA-31 in colon tissues. Furthermore, MSLZ also inhibited the release of inflammatory factors by inhibiting the TLR4/MyD88-dependent pathway in UC mice.

Entities:  

Year:  2019        PMID: 31378906     DOI: 10.26355/eurrev_201908_18553

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Circular RNA_0001187 participates in the regulation of ulcerative colitis development via upregulating myeloid differentiation factor 88.

Authors:  Wei Ouyang; Min Wu; Anshan Wu; Heng Xiao
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Esculentoside A could attenuate apoptosis and inflammation in TNBS-induced ulcerative colitis via inhibiting the nuclear translocation of NF-κB.

Authors:  Ying Liu; Wenhua Wei; Shiwei Liang; Haicheng Fang; Jie Cao
Journal:  Ann Transl Med       Date:  2022-07

3.  Mechanisms of action of anti-inflammatory proteins and peptides with anti-TNF-alpha activity and their effects on the intestinal barrier: A systematic review.

Authors:  Mayara Santa Rosa Lima; Vanessa Cristina Oliveira de Lima; Grasiela Piuvezam; Kesley Pablo Morais de Azevedo; Bruna Leal Lima Maciel; Ana Heloneida de Araújo Morais
Journal:  PLoS One       Date:  2022-08-08       Impact factor: 3.752

Review 4.  Traditional Chinese medicine prescription Shenling BaiZhu powder to treat ulcerative colitis: Clinical evidence and potential mechanisms.

Authors:  Jing Chen; Bixin Shen; Zhengli Jiang
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

5.  Toll-like receptor 4 regulates spontaneous intestinal tumorigenesis by up-regulating IL-6 and GM-CSF.

Authors:  Yun-Jie Shi; Quan-Quan Zhao; Xiao-Shuang Liu; Su-He Dong; Ji-Fu E; Xu Li; Cong Liu; Hao Wang
Journal:  J Cell Mol Med       Date:  2019-10-25       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.